OxiDx launched to maximise oxidative stress technology
Spin-off business OxiDx founded to unlock value from ‘2-tag’ measure for oxidative stress
Stand-alone entity will focus on patented technology developed by Proteomics
International and The University of Western Australia
Proteomics International and its shareholders will own 66 per cent of OxiDx, and The
University of Western Australia will own 33 per cent
Target applications include chronic fatigue, muscular dystrophy, high-performance athletes
and the horse racing industry
Additional Target Industries ,,= Additional Potential Revenue,,NZT
OxiDx launched to maximise oxidative stress technology Spin-off...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.65M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 38.0¢ | $98.01K | 252.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9722 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 44999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |